Latest News

Lawmakers to Trump: Don’t give ‘monopolies’ to companies that develop coronavirus treatments with taxpayer funds

Nearly four dozen lawmakers asked the White House to ensure any treatment for the fast-moving coronavirus that is developed with U.S. taxpayer funds is reasonably priced, an issue that has previously emerged in connection with other nascent medicines due to angst over the cost of prescription drugs.

In a letter sent Thursday, 46 members of Congress urged the Department of Health and Human Service not to issue an exclusive license to any drug maker that develops a coronavirus treatment over concerns that “providing monopoly rights could result in an expensive medicine that is inaccessible, wasting public resources and putting public health at risk in the U.S. and around the globe.”

Read the rest…

Source link

Related posts

STAT Plus: Could FDA use off-label data for drug approvals? It’s possible, agency official says


#Healthcare Providers Mull Clinical #mHealth Applications for #Alexa: there has …


Global Fibrinogen Deficiency Ongoing Clinical Trials – Analysis & Outlook to 2022 –


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy